CSI Market
Sign In | Register

Amedisys Inc (AMED) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AMED Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Amedisys Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2025)
6 Months 		(Mar 31 2025) (Dec 31 2024) (Sep 30 2024) (Jun 30 2024)
Operating Activities
Income90.87
Depreciation & amortization13.49
Amortization of Other Assets0.44
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.88
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-0.05
Share-based Compensation14.75
Income (Loss) from Equity Method Investments-0.06
Gain (Loss) on Contract Termination0.00
Employee Match Expense-
Gains Losses On Sales Of Assets-
Deferred Debt Issuance Costs Written Off-
Goodwill And Intangible Asset Impairment-
Amortization and Impairment of Operating Lease Right Of Use Asset17.40
Increase Decrease In Operating Lease Liability-15.25
Amortization And Impairment Of Operating Lease Right Of Use Asset-
Gain On Termination Of Joint Venture-3.57
Income taxes16.40
Gain (Loss) on Investments-48.09
Increase (Decrease) in Accounts Receivable0.55
Increase (Decrease) in Accounts Payable-9.81
Increase (Decrease) in Accrued Liabilities-15.67
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets3.58
Other Working Capital0.01
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-2.36
Discontinued operations0.00
Net Cash flow from Operating Activities63.52
Investing Activities
Capital Expenditures-2.34
Sale of Capital Items0.02
Payments for (Proceeds from) Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds from Sale of Restricted Investments0.03
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Equity Method Investments0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-2.30
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.50
Long-term debt - borrowings0.00
Long-term debt - repayments-19.55
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.15
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-6.01
Cash Distribution To Noncontrolling Interest-1.26
Increase Decrease In Assets Of Equity Method Investment-
Payments For Repurchase Of Noncontrolling Interest-
Funds Received From Provider Relief Fund Advance-
Proceeds From Borrowings Under Term Loan-
Payments of Ordinary Dividends, Noncontrolling Interest0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-27.17
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow61.20
Total Cash Flow34.06
4 historic quarters locked

Sign in to unlock the full Amedisys Inc cash flow history.

Sign In Create Free Account

About Amedisys Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000896262-25-000065

Figures are derived from filed reports and may be restated. Historical data is subject to revision.